HOPE
Hope Bancorp, Inc.
HOPE has the edge over JPM overall, supported by stronger valuation and stronger fundamentals.
JPM
JPMorgan Chase & Co.
JPM has lower modeled downside risk, despite its lower overall score.
HOPE Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
HOPE's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like HOPE.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
HOPE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.2x | $7.46 | -43% |
| Fair | 10x | $10.89 | -17% |
| Forward | 11x | $13.06 | — |
| Current | 13x | $13.06 | — |
| Expensive | 16x | $16.93 | +30% |
Historical ranges are pointers, not guarantees.
HOPE's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over HOPE in the historical PE scenario, which offers more potential upside but is not a forecast.
HOPE Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for HOPE, but weaker profitability. However, they disagree widely on these estimates.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
HOPE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.18 | +14% |
| Q3 2026 | $1.04 | +167% |
| Q2 2026 | $1.00 | +186% |
| Q1 2026 | $0.52 | -33% |
| Q4 2025 | $0.46 | -44% |
| Q3 2025 | $0.39 | -54% |
| Q2 2025 | $0.35 | -61% |
| Q1 2025 | $0.78 | -22% |
| Q4 2024 | $0.82 | -27% |
HOPE's earnings per share have fallen from their peak: $1.04 over the past year, against $1.81 in early 2022. Its recent earnings include one-off gains.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over HOPE on earnings, with more consistent year-over-year improvement.
HOPE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $157.5M | +11% |
| Q2 2026 | $147.8M | +56% |
| Q1 2026 | $141M | +21% |
| Q4 2025 | $145.8M | +24% |
| Q3 2025 | $142M | +22% |
| Q2 2025 | $94.6M | -19% |
| Q1 2025 | $116.5M | -5.5% |
| Q4 2024 | $118M | -13% |
HOPE's revenue has grown year over year for five quarters in a row: $157M last quarter, up 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 29% | +3.6 points |
| Q2 2026 | 29% | +60 points |
| Q1 2026 | 27% | +3 points |
| Q4 2025 | 27% | +1.1 points |
| Q3 2025 | 26% | -1.8 points |
| Q2 2025 | -32% | -61 points |
| Q1 2025 | 24% | -5.2 points |
| Q4 2024 | 26% | +0.9 points |
HOPE's operating margin was 29% last quarter, up 3.6 points from the same quarter a year ago.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over HOPE on profitability, with a higher operating margin.
HOPE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $146.1M | +210% |
| Q2 2026 | $56M | +712% |
| Q1 2026 | $11.8M | -51% |
| Q4 2025 | $73.4M | +55% |
| Q3 2025 | $47.2M | -22% |
| Q2 2025 | $6.9M | +$35M |
| Q1 2025 | $24M | -13% |
| Q4 2024 | $47.4M | -38% |
HOPE has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
HOPE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +316K shares |
| 1 year | 0% | +30.8K shares |
| 3 years | +6.9% | +8.3M shares |
| 5 years | +4.7% | +5.7M shares |
| Available history | +1.4% | +1.7M shares |
HOPE has 129M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $2M |
| Q1 2026 | $6.7M |
| Q4 2023 | — |
| Q3 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q4 2021 | $2.8M |
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over HOPE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
HOPE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 1.1x | Healthy |
| Q1 2026 | 0.4x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | -1.5x | Net Cash |
| Q2 2025 | -2.0x | Net Cash |
| Q1 2025 | -0.7x | Net Cash |
| Q4 2024 | 0.1x | Very low |
HOPE's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago. Net leverage isn't a meaningful measure for financial services companies like HOPE.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM has the edge over HOPE on leverage, with a lower net debt burden relative to earnings.
HOPE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.0 | Neutral |
| Stochastic | 12.2 | Oversold |
HOPE's weekly RSI is 47 (neutral) and its Stochastic is 12 (oversold).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
HOPE PE vs Financial Services Sector
| Metric | HOPE | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 13x | 3.5% below |
| PE % | 62 | 63 | 1 pt below |
HOPE has the edge over JPM on valuation relative to its sector.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
HOPE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.5 | 3% below |
| 20 week MA | $13.7 | 4.8% below |
| 50 week MA | $12.6 | 3.3% above |
| 100 week MA | $11.7 | 12% above |
| 200 week MA | $11.3 | 16% above |
HOPE has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 16% above its 200-week average.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over HOPE on trend strength, trading above more of its moving averages.
HOPE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $14.8 | $10.8 | -27% |
| 2021 | $10.8 | $14.5 | +35% |
| 2022 | $14.5 | $12.9 | -11% |
| 2023 | $12.9 | $12.1 | -6.4% |
| 2024 | $12.1 | $12.3 | +1.8% |
| 2025 | $12.3 | $11.3 | -8.5% |
| 2026 YTD | $11.3 | $13.1 | +16% |
HOPE has the edge over JPM on returns for 2026, with the stronger performance.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.